890808P

22:0 Trehalose

Avanti Research^™ - A Croda Brand

• 同義詞: D-(+)-trehalose 6,6′-dibehenate
• 經驗公式（希爾表示法）: C₅₆H₁₀₆O₁₃
• CAS號碼: 66758-35-8
• 分子量：: 987.43
• MDL號碼: MFCD00057968
• 分類程式碼代碼: 12352211
• NACRES: NA.25

屬性

• 形狀: powder
• 包裝: pkg of 1 × 25 mg (890808P-25mg); pkg of 1 × 5 mg (890808P-5mg)
• 製造商／商標名: Avanti Research^™ - A Croda Brand
• 應用: vaccine development
• 運輸包裝: dry ice
• 儲存溫度: −20°C
• SMILES 字串: O[C@H]([C@@H](COC(CCCCCCCCCCCCCCCCCCCCC)=O)O[C@H](O[C@@H](O[C@@H]([C@H]([C@@H]1O)O)COC(CCCCCCCCCCCCCCCCCCCCC)=O)[C@@H]1O)[C@@H]2O)[C@@H]2O
• InChI 密鑰: ZLJJDBSDZSZVTF-LXOQPCSCSA-N

描述

一般說明

22:0 Trehalose is a bioactive glycolipid and an analog of mycobacterial cord factor.

應用

22:0 Trehalose has been used as an adjuvant for Chlamydia vaccine. It has also been used as a component in adjuvant DMT (dimethyldioctadecylammonium/monophosphoryl lipid A/trehalose 6,6′-dibehenate (DDA/MPL/TDB)) to prepare DMT liposome adjuvanted CTT3H (polyprotein) vaccine.

生化／生理作用

Incorporation of trehalose 6,6′-dibehenate (TDB) into cationic liposomes composed of the quaternary ammonium compound dimethyldioctadecylammonium (DDA) produce an adjuvant system which induces a powerful cell-mediated immune response and a strong antibody response, desirable for a high number of disease targets. It acts as an immunomodulator. 22:0 Trehalose is considered less toxic and an efficient vaccine adjuvant for tuberculosis.

包裝

5 mL Amber Glass Screw Cap Vial (890808P-25mg)

5 mL Amber Glass Screw Cap Vial (890808P-5mg)

其他說明

For R&D use only. Not for drug, household, or other uses.

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全資訊

• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable